The Social Insurance Institution of Finland
Helsinki, 00250, Finland
NCT Number: NCT06749509
The goal of this observational study is to learn about the effects of two different musculoskeletal rehabilitation programs in working-age people with musculoskeletal disorders. The main question it aims to answer is:
Do musculoskeletal rehabilitation programs A or B improve work ability in people with musculoskeletal disorders?
Participants starting in rehabilitation programs A and B will answer survey questions about their work ability and related factors three times: when starting, immediately after the rehabilitation ends, and 4 months after ending the rehabilitation. Participants in study group C will answer the same questions during the same time period.
Researchers will compare participants in rehabilitation programs A and B to participants in group C, who have musculoskeletal disorders but will not participate in rehabilitation programs. The comparison is done to see if there are differences in the changes in work ability and related factors, such as pain or quality of life.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Helsinki, 00250, Finland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Groups 1 ja 2:
Group 3 (Controls):
Exclusion criteria
Group 3 (Controls):
Kela's rehabilitation course for those with MSD includes two 5-day periods and one 3-day period of face-to-face rehabilitation, which are carried out in a Finnish rehabilitation center over a 9-month period and implemented by a multidisciplinary team of rehabilitation experts. The rehabilitation course is group-based and provided free of charge. The 9-month rehabilitation period also includes calls to the participants before and after rehabilitation. The course is intended for persons over the age of 18 with diagnosed MSD and difficulties coping with work or studies. The course provides support, tools, and coaching to help manage daily life and work with MSD. Self-rehabilitation is an important component of the program. Individual goals based on the GAS method are set, evaluated, and adjusted during the rehabilitation. A medical statement is required when applying for the rehabilitation course.
Kela´s MSD telerehabilitation course is arranged entirely as telerehabilitation, and it includes videoconferencing, online rehabilitation, and group-based rehabilitation days implemented by a multidisciplinary team of rehabilitation experts. Participation does not require particular IT skills, but appropriate equipment (e.g., mobile phone, laptop, tablet computer) is needed. The rehabilitation course is free of charge, and the total duration, including the calls before and after rehabilitation, is approximately 7 months. The course is intended for persons over the age of 18 with diagnosed MSD and difficulties coping with work or studies. The course provides support, tools, and coaching to help manage daily life and work with MSD. Self-rehabilitation is an important component of the program. Individual goals based on the GAS method are set, evaluated, and adjusted during the rehabilitation. A physiotherapist's recommendation is required when applying for the telerehabilitation course
The control participants have an MSD diagnosis and musculoskeletal symptoms. Based on an occupational physiotherapist's brief evaluation they are eligible to apply for Kela's musculoskeletal rehabilitation (the interventions below). By them own choice, however, they will not participate in these rehabilitation programs in the near future. The controls are recruited via two occupational health care producers in the private sector.
Time frame: Baseline (pre-intervention), 4-6 months (after the intervention), 8-10 months (4-month follow-up)
Work Ability Index questionnaire (7-49 points; the higher score indicates better work ability)
Time frame: Baseline (pre-intervention), 4-6 months (after the intervention)
Beck's Depression Inventory (BDI-21) (0-63; the higher score indicates more depressive symptoms)
Time frame: Baseline (pre-intervention), 4-6 months (after the intervention)
World Health Organization Quality of Life Instrument (WHOQOL-BREF) (0-100; the higher score indicates better quality of life)
Time frame: Baseline (pre-intervention), 4-6 months (after the intervention)
PROMIS®-29 Profile v2.1 (without 4 questions concerning depression) (t-score; the higher score indicates more measured quality)
Time frame: Baseline (pre-intervention), 4-6 months (after the intervention), 8-10 months (4-month follow-up)
5 questions from PROMIS®-29 Profile v2.1 concerning pain and 5 questions concerning musculoskeletal pain characteristics
Time frame: Baseline (pre-intervention), 4-6 months (after the intervention)
Return-to-Work Self Efficacy (RTW-SE), modified version (0-66; the higher score indicates better self efficacy)
Time frame: 4-6 months (after intervention)
Goal Attainment Scaling method (GAS)
Time frame: Between January 1, 2024 and June 30, 2026
Register-based data concerning sickness allowance. The sickness allowance is paid as compensation for loss of income due to incapacity for work lasting less than a full year. Periods which have lasted ten days or more are available in Kela's register.
Social Insurance Institution, Finland
Other
Effects of Musculoskeletal Rehabilitation Courses on Work Ability (Tules-kurssit Ja Työkyky)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06045741
Back Pain, Chronic Pain
Tønsberg, Norway
View Trial DetailsNCT06235710
Arthritis, Arthritis, Rheumatoid
Brunssum, Limburg, Netherlands
View Trial DetailsNCT05132400
Chronic Pain, Musculoskeletal Diseases
Portsmouth, Virginia, United States
View Trial DetailsNCT06488547
Behavior, Behavioral Symptoms
Larissa, Biopolis- Larissa, Greece
View Trial Details